{"text": ["After", "Hours", "Most", "Active", "for", "Nov", "15,", "2018", ":", "", "QQQ,", "T,", "MSFT,", "GE,", "INTC,", "NVDA,", "ABBV,", "DWDP,", "HAL,", "FCX,", "CSCO,", "AMD"], "created_at": "2018-11-15 21:56:28"}
{"text": ["After", "Hours", "Most", "Active", "for", "Nov", "15,", "2018", ":", "", "QQQ,", "T,", "MSFT,", "GE,", "INTC,", "NVDA,", "ABBV,", "DWDP,", "HAL,", "FCX,", "CSCO,", "AMD"], "created_at": "2018-11-15 21:56:28"}
{"text": ["ABBVIE", "LEAD", "PLAINTIFF", "DEADLINE", "ALERT:", "Faruqi", "&", "Faruqi,", "LLP", "Encourages", "Investors", "Who", "Suffered", "Losses", "Exceeding", "$100,000", "in", "AbbVie,", "Inc.", "to", "Contact", "the", "Firm"], "created_at": "2018-11-15 21:00:00"}
{"text": ["Exploring", "Clovis", "Oncology\u2019s", "Operational", "Performance"], "created_at": "2018-11-15 19:41:05"}
{"text": ["Understanding", "Clovis", "Oncology\u2019s", "Gross", "Margin", "Trend"], "created_at": "2018-11-15 19:41:05"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "FDA", "Nod", "For", "Mallinckrodt's", "Pain", "Drug,", "AbbVie-Neurocrine", "Report", "Positive", "Elagolix", "Results"], "created_at": "2018-11-15 13:10:31"}
{"text": ["AbbVie", "(ABBV)", "Gains", "As", "Market", "Dips:", "What", "You", "Should", "Know"], "created_at": "2018-11-15 01:10:06"}
{"text": ["AbbVie", "(ABBV)", "Gains", "As", "Market", "Dips:", "What", "You", "Should", "Know"], "created_at": "2018-11-15 01:10:06"}
{"text": ["SHAREHOLDER", "ALERT:", "Pomerantz", "Law", "Firm", "Reminds", "Shareholders", "with", "Losses", "on", "their", "Investment", "in", "AbbVie", "Inc.", "of", "Class", "Action", "Lawsuit", "and", "Upcoming", "Deadline", "\u2013", "ABBV"], "created_at": "2018-11-15 00:45:00"}
